ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 57 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,417,380 | +21.9% | 362,000 | +18.2% | 4.97% | +20.6% |
| Q2 2023 | $6,084,075 | +19.2% | 306,194 | +2.7% | 4.12% | +9.6% |
| Q1 2023 | $5,104,740 | +0.3% | 298,000 | +14.6% | 3.76% | +20.1% |
| Q4 2022 | $5,088,200 | +363.8% | 260,000 | +1200.0% | 3.13% | +947.2% |
| Q4 2020 | $1,097,000 | -83.3% | 20,000 | -94.3% | 0.30% | -72.1% |
| Q1 2018 | $6,563,000 | – | 350,000 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |